IMW 2019 | Maintaining MM CAR T-cell therapy response

Niels van de Donk

Niels van de Donk, MD, PhD, from VU University Medical Center, Amsterdam, The Netherlands, explains how we can maintain CAR T-cell therapy responses in the myeloma space. This interview was speaking at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video